Rockwell Medical (RMTI) Gross Profit (2010 - 2026)

Rockwell Medical (RMTI) has 17 years of Gross Profit data on file, last reported at $2.9 million in Q1 2026.

• Quarterly Gross Profit fell 4.77% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (down 33.86% YoY) and the FY2025 annual result came in at $11.7 million, down 33.11% from the prior year.
• Gross Profit declined to $2.9 million in Q1 2026, from $3.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $6.2 million in Q3 2024 to a low of -$786000.0 in Q1 2022.
• A 5-year average of $2.6 million and a median of $2.6 million in 2023 frame the typical range for Gross Profit.
• The widest YoY moves for Gross Profit: up 766.03% in 2022, down 296.01% in 2022.
• Tracing RMTI's Gross Profit over 5 years: stood at $2.3 million in 2022, then advanced by 22.65% to $2.9 million in 2023, then climbed by 26.52% to $3.6 million in 2024, then gained by 6.8% to $3.9 million in 2025, then decreased by 25.3% to $2.9 million in 2026.
• The last three Gross Profit figures came in at $2.9 million (Q1 2026), $3.9 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.